Surufatinib — a novel oral agent for neuroendocrine tumours
Anna Koumarianou, Gregory Kaltsas
Topics & Concepts
MedicineAngiogenesisNeuroendocrine tumorsImmune systemCancer researchLungTyrosine-kinase inhibitorTyrosine kinaseNeuroendocrine tumourPancreasInternal medicineOncologyImmunologyReceptorCancerNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesPancreatic and Hepatic Oncology Research